Abstract
In total, 124 adult patients in remission after allogeneic hematopoietic SCT (HSCT) participated in a cross-sectional study to assess health-related quality of life (HRQL). Assessment of HRQL was carried out using two questionnaires: the (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy (FACT) with specific modules for BMT (FACT-BMT). Transplanted patients differed from healthy controls in many HRQL-related dimensions in the EORTC QLQ-C30: social functioning 73.4 versus 85.8, P<0.0001; role functioning 74.6 versus 83.3, P<0.004; physical functioning 83.9 versus 89.9, P<0.001; emotional functioning 72.2 versus 82.8, P<0.0001 but were not significant for global HRQL 71.2 versus 75.3, P<0.03. In total, 60% of the patients returned to work after HSCT; 31% part time and 29% full time. Age at HSCT and employment status were significantly associated with HRQL. Other factors such as disease and disease stage and especially the occurrence of late complications did not impact the perception of HRQL. This study suggests that the perception of HRQL after HSCT differs from the general population. Issues to increase work-related capabilities and improve social support need to be addressed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 2005; 23: 599–608.
Heinonen H, Volin L, Uutela A, Zevon M, Barrick C, Ruutu T . Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation. Ann Hematol 2001; 80: 137–143.
Kopp M, Holzner B, Meraner V, Sperner-Unterweger B, Kemmler G, Nguyen-Van-Tam DP et al. Quality of life in adult hematopoietic cell transplant patients at least 5 years after treatment: a comparison with healthy controls. Eur J Haematol 2005; 74: 97–103.
Baker F, Wingard JR, Curbow B, Zabora J, Jodrey D, Fogarty L et al. Quality of life of bone marrow transplant long-term survivors. Bone Marrow Transplant 1994; 13: 589–596.
Sutherland HJ, Fyles GM, Adams G, Hao Y, Lipton JH, Minden MD et al. Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplant 1997; 19: 1129–1136.
Syrjala KL, Chapko MK, Vitaliano PP, Cummings C, Sullivan KM . Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 1993; 11: 319–327.
Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers ME et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 2004; 291: 2335–2343.
Kopp M, Schweigkofler H, Holzner B, Nachbaur D, Niederwieser D, Fleischhacker WW et al. EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison. Eur J Haematol 2000; 65: 97–103.
McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 1997; 19: 357–368.
Miralbell R, Rouzaud M, Grob E, Nouet P, Bieri S, Majno SB et al. Can a total body irradiation technique be fast and reproducible? Int J Radiat Oncol Biol Phys 1994; 29: 1167–1173.
Bieri S, Helg C, Chapuis B, Miralbell R . Total-body irradiation before allogeneic bone marrow transplantation: is more dose better? Int J Radiat Oncol Biol Phys 2001; 49: 1071–1077.
Miralbell R, Bieri S, Mermillod B, Helg C, Sancho G, Pastoors B et al. Renal toxicity after allogeneic bone marrow transplant: the combined effects of total body irradiation and graft versus host disease. J Clin Oncol 1996; 14: 579–585.
Chalandon Y, Roosnek E, Mermillod B, Waelchli L, Helg C, Chapuis B . Can only partial T-cell depletion of the graft before hematopoietic stem cell transplantation mitigate graft-versus-host disease while preserving a graft-versus leukemia reaction? A prospective phase II study. Biol Blood Marrow Transplant 2006; 12: 102–110.
Hale G, Zhang MJ, Bunjes D, Prentice HG, Spence D, Horowitz MM et al. Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection. Blood 1998; 92: 4581–4590.
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295–304.
Mor V, Laliberte L, Morris JN, Wiemann M . The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer 1984; 53: 2002–2007.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365–376.
Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S . Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: The QLQ-C30 (+3). J Clin Oncol 1998; 16: 1188–1196.
Cella D . Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System. Centre on Outcomes, Research and Education (CORE). Northwestern Healthcare and Northwestern University: Evanston, 1997.
Holzner B, Kemmler G, Cella D, De Paoli C, Meraner V, Kopp M et al. Normative data for Functional Assessment of Cancer Therapy. Acta Oncologica 2004; 43: 153–160.
Cox Dr, Snell EJ . The Analysis of Binary Data, 2nd edn. Chapman & Hall: London, 1989.
Heinonen H, Volin L, Uutela A, Zevon M, Barrick C, Ruutu T . Gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transplant 2001; 28: 503–509.
Chiodi S, Spinelli S, Ravera G, Petti AR, Van Lint MT, Lamparelli T et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematology 2000; 110: 614–619.
Bush NE, Donaldson GW, Haberman MH, Dacanay R, Sullivan KM . Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. Biol Blood Marrow Transplant 2000; 6: 576–591.
Wingard JR, Curbow B, Baker F, Piantadosi S . Health, functional status, and employment of adult survivors of bone marrow transplantation. Ann Intern Med 1991; 114: 113–118.
Kopp M, Schweigkofler H, Holzner B, Nachbaur D, Niederwieser D, Fleischhacker WW et al. Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessment. Ann Hematol 1998; 77: 27–32.
Barofsky I (ed). Work: issues and concepts. In: Work and Illness: the Cancer Patient. Praeger: New York, 1989, pp 3–24.
Acknowledgements
We thank Professor M Kopp for his review and critical comments on the paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bieri, S., Roosnek, E., Helg, C. et al. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant 42, 819–827 (2008). https://doi.org/10.1038/bmt.2008.253
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2008.253
Keywords
This article is cited by
-
Impairment of vocational activities and financial problems are frequent among German blood cancer survivors
Scientific Reports (2023)
-
Prevalence and Determinants of Return to Work as a Patient-Centered Outcome in Survivors of Hematopoietic Cell Transplantation
Current Hematologic Malignancy Reports (2022)
-
Relationship between work performance and quality of life in long-term survivors of pediatric and adolescent hematopoietic cell transplant
Journal of Cancer Survivorship (2022)
-
Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma
Bone Marrow Transplantation (2021)
-
The haematopoietic stem cell transplant survivors’ sense of coherence about their experiences: a qualitative study
Supportive Care in Cancer (2020)